Premier (PINC) | Financial Analysis & Statements
Premier Inc. Mid-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
262.9M
Gross Profit
198.6M
75.54%
Operating Income
24.9M
9.46%
Net Income
17.9M
6.80%
EPS (Diluted)
$0.22
Balance Sheet Metrics
Total Assets
3.1B
Total Liabilities
1.6B
Shareholders Equity
1.5B
Debt to Equity
1.02
Cash Flow Metrics
Operating Cash Flow
89.6M
Free Cash Flow
86.2M
Revenue & Profitability Trend
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Premier Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1.0B | 1.3B | 1.3B | 1.4B | 1.7B |
| Cost of Goods Sold | 269.3M | 458.3M | 439.8M | 547.9M | 883.8M |
| Gross Profit | 743.4M | 888.0M | 896.3M | 885.0M | 837.3M |
| Gross Margin % | 73.4% | 66.0% | 67.1% | 61.8% | 48.6% |
| Operating Expenses | |||||
| Research & Development | 2.6M | 3.1M | 4.5M | 4.2M | 3.3M |
| Selling, General & Administrative | 701.4M | 709.7M | 601.6M | 576.9M | 532.3M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 704.1M | 712.8M | 606.1M | 581.0M | 535.7M |
| Operating Income | 1.1M | 128.0M | 242.1M | 260.1M | 256.9M |
| Operating Margin % | 0.1% | 9.5% | 18.1% | 18.2% | 14.9% |
| Non-Operating Items | |||||
| Interest Income | - | 1.3M | - | - | - |
| Interest Expense | 17.2M | - | 14.5M | 11.1M | 12.0M |
| Other Non-Operating Income | 114.2M | 20.5M | 22.4M | 78.0M | 5.7M |
| Pre-tax Income | 98.0M | 149.8M | 250.0M | 326.9M | 250.6M |
| Income Tax | 25.3M | 43.1M | 75.1M | 58.6M | -53.9M |
| Effective Tax Rate % | 25.8% | 28.8% | 30.0% | 17.9% | -21.5% |
| Net Income | 30.8M | 106.7M | 174.9M | 268.3M | 304.6M |
| Net Margin % | 3.0% | 7.9% | 13.1% | 18.7% | 17.7% |
| Key Metrics | |||||
| EBITDA | 232.9M | 257.0M | 398.3M | 403.0M | 411.0M |
| EPS (Basic) | $0.22 | $1.05 | $1.47 | $2.21 | $2.24 |
| EPS (Diluted) | $0.22 | $1.04 | $1.46 | $2.19 | $2.22 |
| Basic Shares Outstanding | 91228000 | 113791000 | 118767000 | 120220000 | 116527000 |
| Diluted Shares Outstanding | 91228000 | 113791000 | 118767000 | 120220000 | 116527000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Premier Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 83.7M | 125.1M | 89.8M | 86.1M | 129.1M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 104.8M | 127.5M | 117.7M | 114.2M | 140.9M |
| Inventory | - | 79.8M | 76.9M | 119.7M | 176.4M |
| Other Current Assets | 84.6M | 80.5M | 60.4M | 65.6M | 68.0M |
| Total Current Assets | 585.8M | 748.0M | 641.6M | 645.6M | 782.3M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 5.1M | 20.6M | 29.3M | 39.5M | 48.2M |
| Goodwill | 2.0B | 2.3B | 2.5B | 2.4B | 2.4B |
| Intangible Assets | 250.8M | 269.3M | 430.0M | 356.6M | 396.6M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 893.4M | 929.4M | 799.7M | 857.5M | 869.9M |
| Total Non-Current Assets | 2.5B | 2.7B | 2.7B | 2.7B | 2.7B |
| Total Assets | 3.1B | 3.4B | 3.4B | 3.4B | 3.5B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 19.6M | 60.4M | 54.4M | 44.6M | 85.4M |
| Short-term Debt | 280.0M | 102.5M | 316.2M | 250.9M | 174.2M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 380.6M | 345.3M | 312.9M | 292.6M | 274.2M |
| Total Current Liabilities | 910.6M | 746.6M | 815.5M | 753.1M | 716.8M |
| Non-Current Liabilities | |||||
| Long-term Debt | 2.0M | 11.2M | 124.1M | 236.4M | 347.4M |
| Deferred Tax Liabilities | 19.2M | 23.2M | 22.9M | 18.8M | 18.5M |
| Other Non-Current Liabilities | 8.9M | 4.4M | 24.3M | 23.8M | 29.8M |
| Total Non-Current Liabilities | 655.9M | 692.7M | 221.7M | 355.1M | 576.2M |
| Total Liabilities | 1.6B | 1.4B | 1.0B | 1.1B | 1.3B |
| Equity | |||||
| Common Stock | 916.0K | 1.1M | 1.3M | 1.2M | 1.2M |
| Retained Earnings | -485.0M | 105.6M | 405.1M | 331.7M | 169.5M |
| Treasury Stock | 161.6M | 250.1M | 250.1M | 250.1M | 0 |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 1.5B | 2.0B | 2.3B | 2.2B | 2.2B |
| Key Metrics | |||||
| Total Debt | 282.0M | 113.7M | 440.3M | 487.3M | 521.7M |
| Working Capital | -324.8M | 1.5M | -173.8M | -107.6M | 65.5M |
Balance Sheet Composition
Premier Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 30.8M | 106.7M | 174.9M | 268.3M | 304.6M |
| Depreciation & Amortization | 117.6M | 129.0M | 133.8M | 129.1M | 121.1M |
| Stock-Based Compensation | 23.2M | 23.3M | 13.7M | 46.2M | 35.4M |
| Working Capital Changes | 72.0M | -14.3M | 26.4M | 14.2M | 14.4M |
| Operating Cash Flow | 289.5M | 117.6M | 426.7M | 520.4M | 401.1M |
| Investing Activities | |||||
| Capital Expenditures | -82.6M | -81.2M | -82.3M | -87.4M | -88.9M |
| Acquisitions | -39.8M | 12.7M | -189.8M | -42.0M | -84.5M |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -102.1M | -68.5M | -273.6M | -139.4M | -174.6M |
| Financing Activities | |||||
| Share Repurchases | -400.2M | -400.0M | 0 | -250.1M | 0 |
| Dividends Paid | -77.4M | -95.2M | -100.2M | -96.5M | -102.8M |
| Debt Issuance | - | - | - | - | - |
| Debt Repayment | -257.5M | -315.9M | -505.9M | -349.2M | -275.7M |
| Financing Cash Flow | -495.7M | -407.7M | -578.3M | -635.6M | -437.4M |
| Free Cash Flow | 318.8M | 215.4M | 362.2M | 356.8M | 318.5M |
| Net Change in Cash | -308.3M | -358.6M | -425.2M | -254.6M | -210.8M |
Cash Flow Trend
Premier Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
166.24
Forward P/E
21.25
Price to Book
1.53
Price to Sales
2.33
PEG Ratio
-2.36
Profitability Ratios
Profit Margin
-3.28%
Operating Margin
11.38%
Return on Equity
0.87%
Return on Assets
3.01%
Financial Health
Current Ratio
0.62
Debt to Equity
21.40
Beta
0.61
Per Share Data
EPS (TTM)
$0.17
Book Value per Share
$18.48
Revenue per Share
$11.58
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| PINC | 2.3B | 166.24 | 1.53 | 0.87% | -3.28% | 21.40 |
| Ge Healthcare | 31.9B | 15.92 | 3.18 | 22.38% | 10.10% | 98.72 |
| Veeva Systems | 26.5B | 29.57 | 3.66 | 13.93% | 28.45% | 1.33 |
| Doximity | 4.4B | 20.29 | 4.56 | 23.82% | 37.54% | 1.09 |
| HealthEquity | 6.6B | 31.61 | 3.14 | 10.19% | 16.39% | 47.53 |
| BrightSpring Health | 9.3B | 100.33 | 5.24 | 5.92% | 1.48% | 143.60 |
Financial data is updated regularly. All figures are in the company's reporting currency.






